- Home
- NCZ vs MIR Comparison
NCZ vs MIR Comparison
Compare NCZ & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCZ
- MIR
- Stock Information
- Founded
- NCZ 2003
- MIR 2005
- Country
- NCZ United States
- MIR United States
- Employees
- NCZ N/A
- MIR N/A
- Industry
- NCZ Finance Companies
- MIR Industrial Machinery/Components
- Sector
- NCZ Finance
- MIR Technology
- Exchange
- NCZ Nasdaq
- MIR Nasdaq
- Market Cap
- NCZ 240.5M
- MIR 2.9B
- IPO Year
- NCZ N/A
- MIR N/A
- Fundamental
- Price
- NCZ $3.17
- MIR $14.04
- Analyst Decision
- NCZ
- MIR Strong Buy
- Analyst Count
- NCZ 0
- MIR 2
- Target Price
- NCZ N/A
- MIR $14.00
- AVG Volume (30 Days)
- NCZ 533.0K
- MIR 2.6M
- Earning Date
- NCZ 01-01-0001
- MIR 10-29-2024
- Dividend Yield
- NCZ 12.16%
- MIR N/A
- EPS Growth
- NCZ N/A
- MIR N/A
- EPS
- NCZ N/A
- MIR N/A
- Revenue
- NCZ N/A
- MIR $821,300,000.00
- Revenue This Year
- NCZ N/A
- MIR $7.10
- Revenue Next Year
- NCZ N/A
- MIR $5.63
- P/E Ratio
- NCZ N/A
- MIR N/A
- Revenue Growth
- NCZ N/A
- MIR 8.34
- 52 Week Low
- NCZ $2.50
- MIR $6.70
- 52 Week High
- NCZ $3.15
- MIR $14.80
- Technical
- Relative Strength Index (RSI)
- NCZ 58.66
- MIR 71.80
- Support Level
- NCZ $3.14
- MIR $10.92
- Resistance Level
- NCZ $3.22
- MIR $14.71
- Average True Range (ATR)
- NCZ 0.05
- MIR 0.58
- MACD
- NCZ -0.00
- MIR 0.17
- Stochastic Oscillator
- NCZ 59.37
- MIR 80.91
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.